The UCSF faculty members are among the 75 new members and 10 international members elected to the National Academy of Medicine, one of the highest honors in the fields of health and medicine.
A new blood test for children with brain tumors offers a safer approach than surgical biopsies and may allow doctors to measure the effectiveness of treatment even before changes are identified on scans.
A UCSF-led consortium has received a $26.2 million award from the U.S. Army Medical Materiel Development Activity to develop treatments for traumatic brain injury.
The University of California has received notice from the American Federation of State, County and Municipal Employees (AFSCME) Patient Care Technical Unit that it will hold a three-day strike across the UC system, beginning October 23, with other unions striking in sympathy.
Scientists at UCSF and Boston Children’s Hospital have developed a new technique for making mice with brains that combine the genetics of two different mouse strains.
Scientists at UCSF have assembled a searchable database of normal human immunity that researchers can now use as an instant comparison group in studies of the immune system and immune dysfunction.
In a new study discovered that variants at a single site on Chromosome 6 are associated with a significantly higher risk of developing erectile dysfunction.
UCSF’s Shuvo Roy has spent the better part of a decade working on technology that could lead to a a surgically implantable bioartificial kidney. Now he is also working with UCSF colleagues to turn that technology into an artificial pancreas.
Ten UCSF postdocs competed to explain complex research in simple language – and in three minutes or less – in the third annual Postdoc Slam held Sept. 26.
The 23rd International AIDS conference, AIDS2020, is returning to the Bay Area for the first time in 30 years, with leadership from UCSF and the International AIDS Society.
UCSF’s Max Krummel was a graduate student in the laboratory of Nobel Prize winner James P. Allison, PhD. Now Krummel is leading an ambitious project at UCSF to expand immunology and immunotherapy to understand and potentially treat new diseases.